Andrew Rabley, MD
Urology · Murray, UTNPI 1770930703
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,481 of the $2,124 with a category attached, or 69.7%. Boston Scientific accounts for 66.5% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $1,323, 7.2 times the $184 reported in 2019. That places this record below the midpoint for urology clinicians in UT, where the typical reported total is $3,296.
Across 32 payments — averaging $66.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$1K
- Cook Medical LLC$264
- Telix Pharmaceuticals$188
- Ambu Inc.$96
- Coloplast$76
- 180 Medical, Inc.$58
- plus $32 from 1 others
What the payments were for
- Travel & lodging$64330%
- Food & beverage$1,48170%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 20 | $1,411 |
| Cook Medical LLC | 6 | $264 |
| Telix Pharmaceuticals | 1 | $188 |
| Ambu Inc. | 1 | $96 |
| Coloplast | 1 | $76 |
| 180 Medical, Inc. | 1 | $58 |
| Laborie Medical Technologies Corp. | 2 | $32 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL KIDNEY STONE DISEASE$643
- ILLUCCIX$375
- LithoVue$170
- Lumenis Pulse 100H$132
How this compares
$2,124 in reported general payments places this provider in the 35th percentile of 96 urology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Potassium Citrate ErPotassium Citrate | 21 | $1,930 |
| Tamsulosin Hcl | 79 | $757 |
| Finasteride | 37 | $722 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 41 | $476 |
| Oxybutynin Chloride | 17 | $123 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 25 | $106 |
| Ciprofloxacin Hcl | 12 | $95 |
| Oxycodone Hcl | 14 | $24 |
Paid to pharmacies, not to this prescriber.
Other urology in Murray
- Sarah ChristiansonMurray$5K
- Steven GangeSlc$1.5M
- William BrantSalt Lake City$290K
- Roscoe NelsonAmerican Fork$152K
- Nathan PursifullAmerican Fork$86K
- Benjamin McCormickSalt Lake City$67K
- Richard MaternSalt Lake City$58K
- Akhil SajiSalt Lake City$49K
- Jeffrey SparenborgProvo$37K
- Daniel SimonRiverton$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.